Pàgina inicial > Articles > Resultats de la cerca: Immunotherapy

Articles

  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Articles 88 registres trobats  anterior11 - 20següentfinal  anar al registre: La cerca s'ha fet en 0.01 segons. 
11.
11 p, 824.1 KB SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019) / Dómine Gómez, Manuel (Hospital Universitario Fundación Jiménez Díaz) ; Moran, T. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Isla, Dolores (Hospital Clínico Universitario "Lozano Blesa" de Zaragoza) ; Martí, J.L. (Hospital General Universitario de Alicante (Alacant, País Valencià)) ; Sullivan, Ivana (Institut d'Investigació Biomèdica Sant Pau) ; Provencio, M. (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Olmedo, M.E. (Hospital Universitario Ramón y Cajal (Madrid)) ; Ponce, S. (Hospital 12 de Octubre (Madrid)) ; Blasco, A. (Consorcio Hospital General Universitario de Valencia. CIBERONC) ; Cobo, M. (Hospital Regional Universitario de Málaga (Carlos Haya)) ; Universitat Autònoma de Barcelona
Small-cell lung cancer (SCLC) accounts for 15% of lung cancers. Only one-third of patients are diagnosed at limited stage. The median survival remains to be around 15-20 months without significative changes in the strategies of treatment for many years. [...]
2020 - 10.1007/s12094-020-02295-w
Clinical & Translational Oncology, Vol. 22 Núm. 2 (january 2020) , p. 245-255  
Registre complet - Creative Commons
12.
21 p, 372.8 KB Comparative analysis of systemic oncological treatments and best supportive care for advanced gastresophageal cancer : A comprehensive scoping review and evidence map / Santero, Marilina (Institut d'Investigació Biomèdica Sant Pau) ; Meade, Adriana-Gabriela (Institut d'Investigació Biomèdica Sant Pau) ; Selva, A (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Acosta-Dighero, Roberto (Universidad de Chile) ; Meza, Nicolás (Universidad de Valparaíso) ; Quintana Ruiz, Maria Jesús (Institut d'Investigació Biomèdica Sant Pau) ; Bracchiglione, Javier (Institut d'Investigació Biomèdica Sant Pau) ; Requeijo, Carolina (Institut d'Investigació Biomèdica Sant Pau) ; Salazar, Josefina (Institut d'Investigació Biomèdica Sant Pau) ; Rodríguez Grijalva, Gerardo (Institut d'Investigació Biomèdica Sant Pau) ; Solà, Ivan (Institut d'Investigació Biomèdica Sant Pau) ; Urrútia, Gerard (Institut d'Investigació Biomèdica Sant Pau) ; Bonfill, X. (Xavier) (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
To identify, describe, and organize the available evidence regarding systemic oncological treatments compared to best supportive care (BSC) for advanced gastresophageal cancer. We conducted a thorough search across MEDLINE (PubMed), EMbase (Ovid), The Cochrane Library, Epistemonikos, PROSPERO, and Clinicaltrials. [...]
2023 - 10.1111/jebm.12539
Journal of Evidence-Based Medicine, Vol. 16 Núm. 2 (june 2023) , p. 216-236  
Registre complet - Creative Commons
13.
11 p, 918.0 KB Brief Research Report : Anti-SARS-CoV-2 Immunity in Long Lasting Responders to Cancer Immunotherapy Through mRNA-Based COVID-19 Vaccination / Sisteré-Oró, Marta (Universitat Pompeu Fabra) ; Wortmann, Diana D. J. (Universitat Pompeu Fabra) ; Andrade, Naína (Universitat Pompeu Fabra) ; Aguilar-Hernández, Andrés (Hospital Quiron-Dexeus Barcelona) ; Mayo de las Casas, Clara (Hospital Universitari Dexeus (Barcelona, Catalunya)) ; Casabal, Florencia Garcia (Hospital Quiron-Dexeus Barcelona) ; Torres, Susana (Hospital Quiron-Dexeus Barcelona) ; Bona Salinas, Eduardo (Hospital Quiron-Dexeus Barcelona) ; Raventos Soler, Laura (Hospital Quiron-Dexeus Barcelona) ; Arcas, Andrea (Hospital Quiron-Dexeus Barcelona) ; Esparre, Carlos (Hospital Quiron-Dexeus Barcelona) ; Garcia, Beatriz (Hospital Universitari Dexeus (Barcelona, Catalunya)) ; Valarezo, Joselyn (Hospital Universitari Dexeus (Barcelona, Catalunya)) ; Rosell, Rafael (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Güerri-Fernández, Robert (Hospital del Mar (Barcelona, Catalunya)) ; Gonzalez-Cao, Maria (Hospital Quiron-Dexeus Barcelona) ; Meyerhans, Andreas (Institució Catalana de Recerca i Estudis Avançats) ; Universitat Autònoma de Barcelona
Cancer patients (CPs) have been identified as particularly vulnerable to SARS-CoV-2 infection, and therefore are a priority group for receiving COVID-19 vaccination. From the patients with advanced solid tumors, about 20% respond very efficiently to immunotherapy with anti-PD1/PD-L1 antibodies and achieve long lasting cancer responses. [...]
2022 - 10.3389/fimmu.2022.908108
Frontiers in immunology, Vol. 13 (july 2022)  
Registre complet - Creative Commons
14.
13 p, 7.8 MB Systemic cellular viroimmunotherapy for canine high-grade gliomas / Cloquell, Ana (Universidad Alfonso X El Sabio) ; Mateo Pampliega, Isidro (Hospital Veterinario VETSIA) ; Gambera, Stefano (Spanish National Centre for Cardiovascular Research (CNIC)) ; Pumarola i Batlle, Martí (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ; Alemany Bonastre, Ramon (Institut Català d'Oncologia) ; Garcia-Castro, Javier (Instituto de Salud Carlos III) ; Perisé-Barrios, Ana Judith (Universidad Alfonso X El Sabio)
Oncolytic viruses constitute a growing field of interest, both in human and veterinary oncology, given that they are particularly helpful for treating non-surgical tumors and disseminated cancer, such as high-grade gliomas. [...]
2022 - 10.1136/jitc-2022-005669
Journal for immunotherapy of cancer, Vol. 10 (december 2022)  
Registre complet - Creative Commons
15.
12 p, 843.6 KB Association of hepatitis B virus infection status with outcomes of non-small cell lung cancer patients undergoing anti-PD-1/PD-L1 therapy / Zhang, Xuanye (Sun Yat-sen University Cancer Center) ; Tian, Dan (Guangdong Academy of Medical Sciences) ; Chen, Yue (The Eighth Affiliated Hospital of Sun Yat-sen University) ; Chen, Chen (Sun Yat-sen University Cancer Center) ; He, Li-Na (Sun Yat-sen University Cancer Center) ; Zhou, Yixin (Sun Yat-sen University Cancer Center) ; Li, Haifeng (Sun Yat-sen University Cancer Center) ; Lin, Zuan (Sun Yat-sen University Cancer Center) ; Chen, Tao (Sun Yat-sen University Cancer Center) ; Wang, Yuhong (Sun Yat-sen University Cancer Center) ; Russo, Alessandro (A.O. Papardo) ; Nadal, Ernest (Hospital Universitari de Bellvitge) ; Passiglia, Francesco (S. Luigi Gonzaga Hospital) ; Soo, Ross Andrew (National University Health System) ; Watanabe, Satoshi (Niigata University Graduate School of Medical and Dental Sciences) ; Morán, Teresa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Oh, In-Jae (Hwasun Hospital) ; Fu, Sha (Sun Yat-sen University) ; Hong, Shaodong (Sun Yat-sen University Cancer Center) ; Zhang, Li (Sun Yat-sen University Cancer Center) ; Universitat Autònoma de Barcelona
The aim of this study was to evaluate the safety and survival outcomes of anti-programmed cell death (PD)-1/programmed cell death-ligand 1 (PD-L1) monotherapy in patients with advanced non-small cell lung cancer (NSCLC) and different hepatitis B virus (HBV) infection status. [...]
2021 - 10.21037/tlcr-21-455
Translational Lung Cancer Research, Vol. 10 (july 2021) , p. 3191-3202  
Registre complet - Creative Commons
16.
13 p, 1.1 MB Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis : treatment response by demographic, clinical, and biomarker subgroups (PROMISE)-a systematic review protocol / Lehnert, Thomas (University Medical Center Hamburg-Eppendorf) ; Röver, Christian (University Medical Center Göttingen) ; Köpke, Sascha (University of Cologne) ; Río, Jordi (Hospital Universitari Vall d'Hebron) ; Chard, Declan (University College London Hospitals) ; Fittipaldo, Andrea V. (Istituto Ricerche Farmacologiche "Mario Negri" IRCCS) ; Friede, Tim (University Medical Center Göttingen) ; Heesen, Christoph (University Medical Center Hamburg-Eppendorf) ; Rahn, Anne C. (University of Lübeck) ; Universitat Autònoma de Barcelona
Multiple sclerosis (MS) is an inflammatory and degenerative disease of the central nervous system with an increasing worldwide prevalence. Since 1993, more than 15 disease-modifying immunotherapies (DMTs) have been licenced and have shown moderate efficacy in clinical trials. [...]
2022 - 10.1186/s13643-022-01997-2
Systematic Reviews, Vol. 11 (july 2022)  
Registre complet - Creative Commons
17.
22 p, 1.4 MB Effect of Local Administration of Meglumine Antimoniate and Polyhexamethylene Biguanide Alone or in Combination with a Toll-like Receptor 4 Agonist for the Treatment of Papular Dermatitis due to Leishmania infantum in Dogs / Martínez-Flórez, Icíar (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ; Guerrero, Maria Jose (Hospital Veterinario Alhaurín el Grande, 29120 Alhaurín el Grande, Spain) ; Dalmau, A (AniCura Mediterrani Hospital Veterinari, 43204 Reus, Spain) ; Cabré, Maria (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ; Alcover, M. Magdalena (Universitat de Barcelona. Departament de Biologia, Sanitat i Medi Ambient) ; Berenguer, Diana (Universitat de Barcelona. Departament de Biologia, Sanitat i Medi Ambient) ; Good, Liam (University of London. Department of Pathobiology and Population Sciences) ; Fisa, Roser (Universitat de Barcelona. Departament de Biologia, Sanitat i Medi Ambient) ; Riera, Cristina (Universitat de Barcelona. Departament de Biologia, Sanitat i Medi Ambient) ; Ordeix, Laura (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ; Solano Gallego, Laia (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals)
Papular dermatitis is a cutaneous manifestation of canine Leishmania infantum infection associated with mild disease. Although it is a typical presentation, nowadays, there is still no established treatment. [...]
2023 - 10.3390/pathogens12060821
Pathogens, Vol. 12 (june 2023)  
Registre complet - Creative Commons
18.
16 p, 1.4 MB Changes in Treatment Patterns and Costs for Lung Cancer Have Not Resulted in Relevant Improvements in Survival : A Population-Based Observational Study in Catalonia / Guarga, Laura (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Paco, Noelia (Servei Català de la Salut) ; Vela, Emili (Institut d'Investigació Biomèdica de Bellvitge) ; Cleries, Montserrat (Institut d'Investigació Biomèdica de Bellvitge) ; Corral, Julieta (Institut d'Investigació Biomèdica de Bellvitge) ; Delgadillo Duarte, Joaquin (Banc de Sang i Teixits) ; Pontes García, Caridad (Institut d'Investigació Biomèdica de Bellvitge) ; Borras, Josep M (Universitat de Barcelona)
Real-world data collect clinical and economic information from daily clinical practice and can support decisions in the context of health evaluation and management. The aim of our retrospective cohort study was to describe the different approaches used for treating lung cancer in Catalonia in 2014 and 2018 and to assess the associated cost and impact on patient survival until December 2021. [...]
2022 - 10.3390/cancers14235791
Cancers, Vol. 14 (november 2022)  
Registre complet - Creative Commons
19.
4 p, 265.6 KB Epigenetic therapies for neuroblastoma : immunogenicity awakens / Jiménez Jiménez, Carlos (Human Technopole) ; Moreno, Lucas (Hospital Universitari Vall d'Hebron) ; Segura, Miguel F. (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
The development of immunotherapies for neuroblastoma remains challenging owing to the low immunogenicity of neuroblastoma cells, as reflected by the low expression of one of the main triggers of immune recognition, the major histocompatibility complex class I (MHC-I). [...]
2023 - 10.1002/1878-0261.13404
Molecular Oncology, Vol. 17 (march 2023) , p. 718-721  
Registre complet - Creative Commons
20.
4 p, 295.4 KB Editorial : Multidisciplinary management of cancer patients with immune-related adverse events from checkpoint inhibitors / Riveiro Barciela, Mar (Hospital Universitari Vall d'Hebron) ; Felip, Enriqueta (Hospital Universitari Vall d'Hebron) ; Suarez-Almazor, María E. (The University of Texas MD Anderson Cancer Center) ; Universitat Autònoma de Barcelona
2023 - 10.3389/fmed.2022.1104382
Frontiers in Medicine, Vol. 9 (january 2023)  
Registre complet - Creative Commons

Articles : 88 registres trobats   anterior11 - 20següentfinal  anar al registre:
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem